CIK: 0001281446 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $308,414 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRON | DISC MEDICINE INC | 250,000 | $19,853 | 6.4% | $84.50 | 0.0% | COM | 254604101 |
| RAPT | RAPT THERAPEUTICS INC | 581,187 | $19,685 | 6.4% | $31.06 | 0.0% | COM NEW | 75382E208 |
| VOR | VOR BIOPHARMA INC | 1,370,107 | $17,921 | 5.8% | $18.62 | 0.0% | COM NEW | 929033207 |
| KALV | KALVISTA PHARMACEUTICALS INC | 685,632 | $11,073 | 3.6% | $13.24 | 0.0% | COM | 483497103 |
| CTNM | CONTINEUM THERAPEUTICS INC | 800,000 | $9,144 | 3.0% | $11.41 | 0.0% | CL A | 21217B100 |
| FULC | FULCRUM THERAPEUTICS INC | 800,000 | $9,048 | 2.9% | $10.18 | 0.0% | COM | 359616109 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 300,000 | $6,900 | 2.2% | $32.88 | 0.0% | COM | 90400D108 |
| CGEM | CULLINAN THERAPEUTICS INC | 634,032 | $6,562 | 2.1% | $9.02 | 0.0% | COM | 230031106 |
| EVMN | EVOMMUNE INC | 325,000 | $5,564 | 1.8% | $18.78 | 0.0% | COM SHS | 30054Y107 |
| SLN | SILENCE THERAPEUTICS PLC | 808,032 | $4,913 | 1.6% | $6.08 | — | ADS | 82686Q101 |
| CLYM | CLIMB BIO INC | 979,534 | $3,918 | 1.3% | $2.40 | 0.0% | COM | 28658R106 |
| AVTX | AVALO THERAPEUTICS INC | 124,666 | $2,264 | 0.7% | $16.88 | 0.0% | COM NEW | 05338F306 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 374,000 (+23.0%) | $28,230 (+133.7%) | 9.2% | $42.82 | +47.1% | COM | 03770N101 |
| IMVT | IMMUNOVANT INC | 750,000 (+50.0%) | $19,065 (+136.5%) | 6.2% | $19.88 | +12.2% | COM | 45258J102 |
| JBIO | JADE BIOSCIENCES INC | 806,273 (+27.5%) | $12,441 (+127.9%) | 4.0% | $24.47 | -52.1% | COM NEW | 008064206 |
| DNTH | DIANTHUS THERAPEUTICS INC | 350,000 (+31.7%) | $14,424 (+37.9%) | 4.7% | $28.73 | +34.9% | COM | 252828108 |
| SLNO | SOLENO THERAPEUTICS INC | 400,000 (+77.8%) | $18,520 (+21.8%) | 6.0% | $65.69 | -16.5% | COM | 834203309 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,750,000 (+2.9%) | $21,140 (-8.5%) | 6.9% | $3.96 | +242.6% | COM | 03237H101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S SPONSORED ADR | 75,000 | $14,911 | 4.8% | $198.81 | — | — | 04351P101 |
| ABVX | ABIVAX SA SPONSORED ADS | 150,000 | $12,735 | 4.1% | $12.06 | — | — | 00370M103 |
| CYTK | CYTOKINETICS INC COM NEW | 150,000 | $8,244 | 2.7% | $51.61 | +20.5% | — | 23282W605 |
| XENE | XENON PHARMACEUTICALS INC | 200,000 | $8,030 | 2.6% | $41.35 | +1.6% | — | 98420N105 |
| IONS | IONIS PHARMACEUTICALS INC | 80,000 | $5,234 | 1.7% | $35.97 | +109.3% | — | 462222100 |
| — | AKERO THERAPEUTICS INC | 103,848 | $4,931 | 1.6% | $53.36 | — | — | 00973Y108 |
| TSHA | TAYSHA GENE THERAPIES INC COM SHS | 1,500,000 | $4,905 | 1.6% | $2.17 | +123.5% | — | 877619106 |
| DBVT | DBV TECHNOLOGIES S A SPONSORED ADS | 378,594 | $3,786 | 1.2% | $9.17 | — | — | 23306J309 |
| LEGN | LEGEND BIOTECH CORP SPONSORED ADS | 113,460 | $3,700 | 1.2% | $34.87 | — | — | 52490G102 |
| ABSI | ABSCI CORPORATION | 796,438 | $2,421 | 0.8% | $2.76 | +31.8% | — | 00091E109 |
| HRMY | HRMY 10/17/2025 40 Call | 85,000 | $2,343 | 0.8% | — | — | CALL | 413197104 |
| PLRX | PLIANT THERAPEUTICS INC | 850,000 | $1,258 | 0.4% | $16.18 | -90.7% | — | 729139105 |
| CAPR | CAPR 12/19/2025 7.5 Put | 87,700 | $632 | 0.2% | — | — | PUT | 14070B309 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RZLT | REZOLUTE INC | 951,809 (-61.2%) | $2,246 (-90.3%) | 0.7% | $4.03 | +94.6% | COM NEW | 76200L309 |
| NKTR | NEKTAR THERAPEUTICS | 210,732 (-29.8%) | $8,910 (-47.8%) | 2.9% | $33.10 | +69.1% | COM NEW | 640268306 |
| PHVS | PHARVARIS N V | 82,800 (-46.6%) | $2,298 (-40.6%) | 0.7% | $22.18 | +8.6% | COM | N69605108 |
| NGNE | NEUROGENE INC | 350,000 (-21.7%) | $7,210 (-6.9%) | 2.3% | $14.71 | +69.2% | COM | 64135M105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZURA | ZURA BIO LTD | 3,815,930 | $19,995 | 6.5% | $5.64 | -29.9% | CLASS A ORD SHS | G9TY5A101 |
| UPB | UPSTREAM BIO INC | 300,000 | $8,145 | 2.6% | $22.33 | +11.5% | COM | 91678A107 |
| CNTX | CONTEXT THERAPEUTICS INC | 4,683,711 | $6,885 | 2.2% | $1.72 | -32.2% | COM | 21077P108 |
| ORKA | ORUKA THERAPEUTICS INC | 183,330 | $5,557 | 1.8% | $14.82 | +88.0% | COM | 687604108 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 1,200,000 | $9,060 | 2.9% | $5.44 | +13.3% | COM | 29842P105 |
| UNCY | UNICYCIVE THERAPEUTICS INC | 796,558 | $4,596 | 1.5% | $6.18 | -13.7% | COM NEW | 90466Y202 |
| SANA | SANA BIOTECHNOLOGY INC | 700,000 | $2,849 | 0.9% | $3.62 | +23.9% | COM | 799566104 |